Addressing Prescription Drug Abuse and Overdose: Following is Texas Medical Association policy on addressing prescription drug abuse and overdose:
- That TMA collaborate with state and local public health agencies to promote increased public education programming on the misuse of prescribed medications, support community programs such as ‘take back’ programs, and targeted programs for special populations, particularly women of reproductive age and families with adolescents and teenagers.
- That TMA endorse the education of health care workers and opioid users about the use of naloxone (and other opioid antagonists) in preventing opioid overdose fatalities.
- That TMA implement a plan to promote physician awareness and participation in educational programs on pain relief.
- That TMA support continued expansion of public funding for treatment and recovery support for persons at risk of substance use and misuse, with a priority given to programs for pregnant and postpartum women.
- That TMA support improved access to substance use treatment, especially through co-location of physical health, mental health, and substance use services and through wider availability of evidence-based medication-assisted treatments.
- That TMA advocate for legislation that (1) allows for appropriate storage and for a trained individual, acting under a standing order issued by a physician, to administer an opioid antagonist to prevent deaths from opioid overdose (2) allows first responders, such as police and fire fighters to have access to and administer an opioid antagonist in the event of an emergency overdose (3) reduces barriers for medical professionals to prescribe and dispense naloxone (or other opioid antagonists) to family members and friends of an identified patient, and for administrators to do so without fear of legal repercussions, as described as Third Party Prescription/Standing Order Distribution.
- That TMA support providing legal protection from drug possession charges for persons seeking medical attention after overdose, as described in model 911 Good Samaritan fatal overdose prevention laws (CSPH and TF-BH Joint Rep. 1-A-15).
Last Updated On
June 20, 2019